Diversified Healthcare Trust (DHC)
| Market Cap | 2.05B +271.9% |
| Revenue (ttm) | 1.52B +0.4% |
| Net Income | -320.18M |
| EPS | -1.33 |
| Shares Out | 242.11M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $0.04 (0.47%) |
| Ex-Dividend Date | Apr 21, 2026 |
| Volume | 1,372,371 |
| Open | 8.10 |
| Previous Close | 8.09 |
| Day's Range | 7.90 - 8.48 |
| 52-Week Range | 2.90 - 8.48 |
| Beta | 2.32 |
| Analysts | Strong Buy |
| Price Target | 8.00 (-5.33%) |
| Earnings Date | May 4, 2026 |
About DHC
Diversified Healthcare Trust is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of September 30, 2025, DHC’s approximately 6.7 billion US dollars portfolio included 335 properties in 34 states and Washington, D.C., with more than 26,000 senior living units, approximately 6.9 million square feet of medica... [Read more]
Financial Performance
In 2025, DHC's revenue was $1.54 billion, an increase of 2.84% compared to the previous year's $1.50 billion. Losses were -$285.89 million, -22.79% less than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for DHC stock is "Strong Buy." The 12-month stock price target is $8.0, which is a decrease of -5.33% from the latest price.
News
Diversified Healthcare Trust price target raised to $10 from $9.50 at Maxim
Maxim raised the firm’s price target on Diversified Healthcare Trust (DHC) to $10 from $9.50 and keeps a Buy rating on the shares. The company’s Q1 results saw much stronger
Diversified Healthcare Trust Earnings Call Transcript: Q1 2026
First quarter results exceeded expectations with strong NOI and margin growth, driven by operational improvements and disciplined capital allocation. Guidance for 2026 was reaffirmed, with continued momentum expected in SHOP and medical office segments.
Diversified Healthcare Trust reports Q1 FFO 14c, consensus 13c
Reports Q1 revenue $366.5M, one estimate $371.0M.
Diversified Healthcare Trust Announces First Quarter 2026 Results
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended March 31, 2026, which can be found at the Quarterly Reports secti...
Diversified Healthcare Trust initiated with a Buy at Freedom Broker
Freedom Broker initiated coverage of Diversified Healthcare Trust (DHC) with a Buy rating and $9.40 price target The firm’s positive view is supported by a multi-year recovery in senior housing
Maxim starts Diversified Healthcare Trust at Buy on strong FY26 growth outlook
As previously reported, Maxim initiated coverage of Diversified Healthcare Trust (DHC) with a Buy rating and $9.50 price target The firm notes that the company’s 2025 repositioning is now complete
Diversified Healthcare Trust initiated with a Buy at Maxim
Maxim initiated coverage of Diversified Healthcare Trust (DHC) with a Buy rating and $9.50 price target
Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). Thi...
Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its first quarter 2026 financial results after the Nasdaq close...
Diversified Healthcare Trust price target raised to $8.50 from $6.50 at B. Riley
B. Riley analyst John Massocca raised the firm’s price target on Diversified Healthcare Trust (DHC) to $8.50 from $6.50 and keeps a Buy rating on the shares. The firm says
Diversified Healthcare Trust Earnings Call Transcript: Q4 2025
Delivered strong Q4 and full-year results with significant NOI and margin growth, reduced leverage, and robust operational execution. 2026 guidance anticipates further NOI and margin expansion, supported by disciplined capital allocation and favorable industry trends.
Diversified Healthcare Trust Announces Fourth Quarter 2025 Results
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended December 31, 2025 and provided full year 2026 financial guidance,...
Diversified Healthcare Trust Fourth Quarter 2025 Conference Call Scheduled for Tuesday, February 24th
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its fourth quarter 2025 financial results after the Nasdaq clos...
Diversified Healthcare Trust Announces 2025 Dividend Allocation
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that the characterization of dividends for 2025 income tax reporting purposes is as follows: DHC Common Share...
Diversified Healthcare Trust Provides Business Update
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) (“DHC”) today provided a business update regarding its capital recycling program, the full repayment of its 2026 zero coupon ...
Diversified Healthcare Trust price target raised to $6.50 from $5.50 at B. Riley
B. Riley analyst John Massocca raised the firm’s price target on Diversified Healthcare Trust (DHC) to $6.50 from $5.50 and keeps a Buy rating on the shares. Despite the recent
RBC upgrades Diversified Healthcare to Sector Perform on seniors tailwinds
RBC Capital analyst Michael Carroll upgraded Diversified Healthcare Trust (DHC) to Sector Perform from Underperform with a price target of $5, up from $3. The firm sees the company’s senior
Diversified Healthcare upgraded to Sector Perform at RBC Capital
RBC Capital analyst Michael Carroll upgraded Diversified Healthcare Trust (DHC) to Sector Perform from Underperform with a price target of $5, up from $3.
Diversified Healthcare Trust Earnings Call Transcript: Q3 2025
Q3 revenue rose 4% year-over-year to $388.7M, with SHOP segment NOI up 7.8% and occupancy at 81.5%. Transition of 116 communities to new operators is nearly complete, supporting margin and cash flow growth. No debt maturities until 2028 after 2026 bond repayment.
Diversified Healthcare Trust Announces Third Quarter 2025 Results
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended September 30, 2025, which can be found at the Quarterly Reports s...
Discovery Senior Living Enters Management Agreements with Diversified Healthcare Trust, Deepens Industry Leadership Position Adding a 42 Community, Multi-State Portfolio
Bonita Springs, Florida--(Newsfile Corp. - October 8, 2025) - Discovery Senior Living ("Discovery" or the "Company") and its affiliated subsidiaries, one of the most trusted and the largest privately ...
Diversified Healthcare Trust Provides Update Regarding the 116 AlerisLife Management Agreements Transitioning to New Operators
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) (“DHC”) today reiterated that, as part of the previously disclosed wind-down of AlerisLife Inc. (“AlerisLife”), the managemen...
Diversified Healthcare Trust Third Quarter 2025 Conference Call Scheduled for Tuesday, November 4th
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its third quarter 2025 financial results after the Nasdaq close...
Diversified Healthcare Trust price target raised to $5.50 from $4.50 at B. Riley
B. Riley raised the firm’s price target on Diversified Healthcare Trust (DHC) to $5.50 from $4.50 and keeps a Buy rating on the shares. The company’s greater capital flexibility post
Diversified Healthcare Trust Prices $375 Million of Senior Secured Notes Due October 2030
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) (“DHC”) today announced it has priced $375 million aggregate principal amount of 7.25% senior secured notes due October 2030....